
United States · Medical Device startup
Regenesis Biomedical focuses on the development of non-invasive regenerative medicine products.
Funding reportedLast round: Series C
Funding, as reported
From the SEC filings it signed: 2 on the team.
On the board, as filediChuck LundenHenry NewmanJack AhrensJohn VorisPeter SheehanTom Greer
Add your raise, your deck and your story, and put Regenesis Biomedical in front of investors. Or tell us what we have wrong.